Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomasRaúl M. Luque, Justo P. Castaño, Alberto Moreno-Carazo et al.|Cancer Letters|2015Cited by 91